TORONTO, April 30, 2020 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces that it has entered into an exclusive agreement with Medlive, a leading marketer and distributor of pharmaceutical products to clinics, hospitals and pharmacies in southern Brazil. Through this agreement physicians in Medlive’s extensive network will receive medical education and training related to Khiron products.
DALLAS, April 30, 2020 /PRNewswire/ — Puration, Inc. (USOTC: PURA) today released CBD business acquisition campaign update from CEO Brian Shibley. The company launched the campaign in January this year and subsequently secured a $5 million investment to back the campaign in February. Two acquisitions have already been closed and the company recently announced entering into due-diligence engagements on three more prospective acquisition opportunities. The campaign has gained momentum since January and management anticipates accelerated momentum yet to come with plans for more investment capital to fuel the campaign and market conditions evolving in favor of the campaign. The update for expanding into the CBD market expected to reach as high as $20 billion as soon as 2024 is included in its entirety below within in this release.
Florida Exclusive Launch with Trulieve Represents Continued Partner Growth of Blue River’s Award-Winning Products
VANCOUVER, April 30, 2020 /CNW/ – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided a corporate update on its recent activities and the impact of COVID-19 on the market and operations.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES/
REHOVOT, Israel, April 30, 2020 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2019 with the U.S. Securities and Exchange Commission (the “SEC”).
Print Versions of the Iconic Publications Maintain 91%+ Pick Up Rates
Another major Canadian music festival is forced to cancel due to the COVID-19 pandemic. The independent music festival Bass Coast, officially announced they will not return in 2020. The EDM festival was set to take place on…
There’s nothing better than getting stoned and munching on the saltiest snacks you can find at the convenience store. Before you spark your next joint, make sure to buy these 7 snacks for salt-loving stoners…
NEW YORK and TORONTO, April 29, 2020 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, announced today that, as a result of the logistics and delays caused by the COVID-19 pandemic, the Company will be relying on the general order of the Ontario Securities Commission (the “OSC”) made under Ontario Instrument 51-502 entitled “Temporary Exemption from Certain Corporate Finance Requirements” (“OSC Instrument 51-502”), dated March 23, 2020, to postpone the filing of its annual financial statements and accompanying management’s discussion and analysis for the financial year ended December 31, 2019 (collectively, the “Annual Filings”) and the interim financial statements and accompanying management’s discussion and analysis for the three months ended March 31, 2020 (collectively, the “Interim Filings”).